![](https://investorshub.advfn.com/uicon/538838.png?cb=1613909833)
Tuesday, March 27, 2018 7:44:38 PM
Was LDN in stage 3 trials before this announcement so this a continuation of the trial from a few years ago, or a completely new trial all together?
Someone correct me if I'm wrong, but I believe the following is the last publication regarding the alleged 2013 Phase 3 FDA meeting for Crohn's.
https://backend.otcmarkets.com/otcapi/company/financial-report/103898/content
So basically, it sounds like the meeting never actually happened in 2013.
There was also this publication from a couple days before...
https://backend.otcmarkets.com/otcapi/company/financial-report/103732/content
Then nothing ever came of it.
So actually HAVING the meeting now in January 2018 is further along than we got in 2013.
FEATURED Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • Sep 10, 2024 11:00 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Nightfood Holdings Inc. Completes Major Step on Uplist Journey by Closing Strategic All-Stock Acquisition of CarryoutSupplies.com • NGTF • Sep 10, 2024 8:15 AM
Element79 Gold Corp. Announces Sale of 100% Interest in Elder Creek, North Mill Creek, and Elephant Projects to 1472886 B.C. Ltd. • ELEM • Sep 9, 2024 9:34 AM
North Bay Resources Commences Gold Shipments, Fran Gold Project, British Columbia; Enters Taber Gold Mine JV, Sierra County, California • NBRI • Sep 9, 2024 9:15 AM
Simple Stock Loans Announces Unique Solutions For Investors Looking for Alternative Liquidity Amidst Recent Small Cap Rally Sep 6, 2024 9:30 AM